Archives
  • Catalyzing Game Changes: Werner Lanthaler's Vision to Tackle Global Health and Ecological Challenges

    Dr. Werner Lanthaler, founder and CEO of WLanholding GmbH, is widely recognized in the biotech industry for his visionary strategic investment philosophy. His recent investments in companies such as Proxygen GmbH (specializing in molecular glue degradation), Cerabyte GmbH (pioneering data storage solutions), and Solgate GmbH (focused on molecular-gate targeting) might initially appear to be unrelated but are part of a larger strategy aimed at building a strong portfolio that drives growth in the high-tech life sciences and sustainability sector.